메뉴 건너뛰기




Volumn 29, Issue 7, 2011, Pages

Validation of a new risk assessment model for predicting adverse events in children with fever and chemotherapy-induced neutropenia

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DEXAMETHASONE; HEMOGLOBIN; MERCAPTOPURINE; METHOTREXATE; VINCRISTINE;

EID: 79952358568     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.32.7767     Document Type: Letter
Times cited : (30)

References (5)
  • 1
    • 0034004453 scopus 로고    scopus 로고
    • 'Low-risk' prediction rule for pediatric oncology patients presenting with fever and neutropenia
    • Klaassen RJ, Goodman TR, Pham B, et al: "Low-risk" prediction rule for pediatric oncology patients presenting with fever and neutropenia. J Clin Oncol 18:1012-1019, 2000 (Pubitemid 30123777)
    • (2000) Journal of Clinical Oncology , vol.18 , Issue.5 , pp. 1012-1019
    • Klaassen, R.J.1    Goodman, T.R.2    Pham, B.3    Doyle, J.J.4
  • 4
    • 77951637541 scopus 로고    scopus 로고
    • Predicting adverse events in children with fever and chemotherapy-induced neutropenia: The prospective multicenter SPOG 2003 FN study
    • Ammann RA, Bodmer N, Hirt A, et al: Predicting adverse events in children with fever and chemotherapy-induced neutropenia: The prospective multicenter SPOG 2003 FN study. J Clin Oncol 28:2008-2014, 2010
    • (2010) J Clin Oncol , vol.28 , pp. 2008-2014
    • Ammann, R.A.1    Bodmer, N.2    Hirt, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.